TALK vs. LTRN
TALK (Talkspace, Inc.) and LTRN (Lantern Pharma Inc.) are both stocks. Both are in the Healthcare sector — TALK in Medical Care Facilities, LTRN in Biotechnology. Over the past 5 years, TALK returned -12.19%/yr vs -25.86%/yr for LTRN. At a 0.16 correlation, their price movements are largely independent.
Performance
TALK vs. LTRN - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, TALK achieves a 43.53% return, which is significantly higher than LTRN's 12.21% return.
TALK
- 1D
- -0.19%
- 1M
- 0.19%
- YTD
- 43.53%
- 6M
- 62.81%
- 1Y
- 52.79%
- 3Y*
- 71.66%
- 5Y*
- -12.19%
- 10Y*
- —
LTRN
- 1D
- -9.09%
- 1M
- 52.47%
- YTD
- 12.21%
- 6M
- -3.95%
- 1Y
- 5.59%
- 3Y*
- -12.24%
- 5Y*
- -25.86%
- 10Y*
- —
TALK vs. LTRN - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|---|
TALK Talkspace, Inc. | 43.53% | 17.48% | 21.65% | 316.19% | -69.02% | -81.78% | 7.03% |
LTRN Lantern Pharma Inc. | 12.21% | -5.02% | -25.47% | -29.14% | -24.31% | -58.55% | 57.53% |
Correlation
The correlation between TALK and LTRN is 0.10, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.10 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.19 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.18 |
Correlation (All Time) Calculated using the full available price history since Jul 31, 2020 | 0.16 |
Fundamentals
TALK:
$905.26M
LTRN:
$38.26M
TALK:
$0.01
LTRN:
-$1.45
TALK:
8.01
LTRN:
11.10
TALK:
$238.37M
LTRN:
$0.00
TALK:
$100.68M
LTRN:
$0.00
TALK:
$6.16M
LTRN:
-$16.42M
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
TALK vs. LTRN — Risk / Return Rank
TALK
LTRN
TALK vs. LTRN - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Talkspace, Inc. (TALK) and Lantern Pharma Inc. (LTRN). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| TALK | LTRN | Difference | |
|---|---|---|---|
Sharpe ratioReturn per unit of total volatility | 1.11 | 0.06 | +1.05 |
Sortino ratioReturn per unit of downside risk | 1.90 | 0.83 | +1.07 |
Omega ratioGain probability vs. loss probability | 1.24 | 1.12 | +0.13 |
Calmar ratioReturn relative to maximum drawdown | 1.69 | 0.07 | +1.62 |
Martin ratioReturn relative to average drawdown | 4.11 | 0.15 | +3.96 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| TALK | LTRN | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 1.11 | 0.06 | +1.05 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | -0.18 | -0.30 | +0.13 |
Sharpe Ratio (All Time)Calculated using the full available price history | -0.17 | -0.26 | +0.09 |
Drawdowns
TALK vs. LTRN - Drawdown Comparison
The maximum TALK drawdown since its inception was -95.17%, roughly equal to the maximum LTRN drawdown of -94.89%. Use the drawdown chart below to compare losses from any high point for TALK and LTRN.
Loading charts...
Drawdown Indicators
| TALK | LTRN | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -95.17% | -94.89% | -0.28% |
Max Drawdown (1Y)Largest decline over 1 year | -31.32% | -78.95% | +47.63% |
Max Drawdown (3Y)Largest decline over 3 years | -56.35% | -89.48% | +33.13% |
Max Drawdown (5Y)Largest decline over 5 years | -94.16% | -93.02% | -1.14% |
Current DrawdownCurrent decline from peak | -56.94% | -84.49% | +27.55% |
Average DrawdownAverage peak-to-trough decline | -68.57% | -66.20% | -2.37% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 14.34% | 37.12% | -22.78% |
Volatility
TALK vs. LTRN - Volatility Comparison
The current volatility for Talkspace, Inc. (TALK) is 0.90%, while Lantern Pharma Inc. (LTRN) has a volatility of 33.75%. This indicates that TALK experiences smaller price fluctuations and is considered to be less risky than LTRN based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| TALK | LTRN | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 0.90% | 33.75% | -32.85% |
Volatility (6M)Calculated over the trailing 6-month period | 31.23% | 89.61% | -58.38% |
Volatility (1Y)Calculated over the trailing 1-year period | 47.71% | 96.91% | -49.20% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 69.27% | 85.34% | -16.07% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 64.94% | 85.19% | -20.25% |
Dividends
TALK vs. LTRN - Dividend Comparison
Neither TALK nor LTRN has paid dividends to shareholders.
Financials
TALK vs. LTRN - Financials Comparison
This section allows you to compare key financial metrics between Talkspace, Inc. and Lantern Pharma Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
Frequently Asked Questions
TALK and LTRN have a correlation of 0.10, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
LTRN has higher volatility (33.75%) compared to TALK (0.90%). In terms of maximum drawdown, TALK dropped -95.17% vs LTRN's -94.89%.
TALK currently has the higher Sharpe Ratio (1.11 vs 0.06), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for TALK and LTRN
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer